
Home » Pipeline
Pipeline
Company | Drug/Device | Medical Condition | Status |
---|---|---|---|
Prana Biotechnology Ltd | PBT434 | Parkinsonian diseases | Phase I trial initiated |
Poxel SA | Imeglimin | Metabolic diseases, including type 2 diabetes and non-alcoholic steatohepatitis (NASH) | Phase III trial initiated enrolling 403 subjects in the U.S. |
Cellerant Therapeutics, Inc. | romyelocel-L (human myeloid progenitor cells) | serious bacterial and fungal infections in patients with de novo acute myeloid leukemia (AML) undergoing induction chemotherapy | RMAT designation granted by the FDA |
Merck & Company | KEYTRUDA in combination with carboplatin-paclitaxel or nab-paclitaxel | First-line treatment for metastatic squamous non-small cell lung cancer (NSCLC) | Priority Review granted for sBLA by the FDA |
Merz Neurosciences | Xeomin (incobotulinumtoxinA) | chronic drooling in adults with neurodegenerative diseases | sBLA approved by the FDA |
Compugen Ltd | COM701 (first-in-class immunioncology therapeutic antibody targeting PVRIG in patients | advanced solid tumors | IND clearance granted by the FDA |
Elite Pharmaceuticals, Inc. | generic Percocet (Oxycodone Hydrochloride and Acetaminophen, USP CII) | management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate | aNDA approval granted by the FDA |
Acadia Pharmaceuticals Inc. | NUPLAZID (pimavanserin) capsule | Parkinson’s disease psychosis | Approval granted by the FDA |
Pulmonx Inc. | Zephyr Endobronchial Valve (Zephyr Valve) | severe emphysema | Approval granted by the FDA |
Dermira | Qbrexza | excessive underarm sweating due to primary axillary hyperhidrosis | Approval granted by the FDA |
ReCor Medical | Paradise Ultrasound Denervation System | treatment of Hypertension | Approval granted by the FDA |
Alkermes plc | Aristada Initio (aripiprazole lauroxil) | schizophrenia in adults | Approval granted by the FDA |
Upcoming Events
-
14Apr